References
- OZDOGAN H., UGURLU S. Familial Mediterranean fever. Presse Med. 2019;48(1 Pt 2):e61–e76.
- BEN-CHETRIT E., TOUITOU I. Familial Mediterranean fever in the world. Arthritis Rheum. 2009;61(10):1447–1453.
- YAZDI AS., GHORESCHI K. The interleukin-1 family. Adv Exp Med Biol. 2016;941:21–29.
- CAYROL C., GIRARD JP. Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol Rev. 2018;281(1):154–168.
- CHACKERIAN AA., OLDHAM ER., MURPHY EE., SCHMITZ J., PFLANZ S., KASTELEIN RA. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol. 2007;179(4):2551–2555.
- GUO H., BOSSILA EA., MA X., ZHAO C., ZHAO Y. Dual immune regulatory roles of interleukin-33 in pathological conditions. Cells. 2022;11(20):3237.
- HARDMAN C., OGG G. Interleukin-33, friend and foe in type-2 immune responses. Curr Opin Immunol. 2016;42:16–24.
- CAYROL C., GIRARD JP. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol. 2014;31:31–37.
- DUAN L., CHEN J., GONG F., SHI G. The role of IL-33 in rheumatic diseases. Clin Dev Immunol. 2013;2013:924363.
- UMAR M., MEGARBANE A., SHAN J., SYED N., CHOUERY E., ALIYEV E., et al. Genome sequencing unveils mutational landscape of the familial Mediterranean fever: potential implications of IL33/ST2 signalling. J Cell Mol Med. 2020;24(19):11294–11306.
- DINCER ABK., SEZER S., GULOKSUZ EGA., YAYLA ME., TORGUTALP M., YURTERI EU., et al. Does IL33/Sst2 pathway play a role in the pathogenesis of familial Mediterranean fever? Ankara Univ Tip Fak Mecm. 2022;75(3):406–412.
- ALTINER SE., CERCI P., EKINCI A., INAL A., KESKIN GO. Interleukin-33 and familial Mediterranean fever: a novel inflammatory cytokine and a common autoinflammatory disease. Asthma Allergy Immunol. 2024;22(2):138–145.
- SOHAR E., GAFNI J., PRAS M., HELLER H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med. 1967;43(2):227–253.
- DEMIRKAYA E., ACIKEL C., HASHKES P., GATTORNO M., GUL A., OZDOGAN H., et al. Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF). Ann Rheum Dis. 2016;75(6):1051–1056.
- OZEN S., DEMIRKAYA E., ERER B., LIVNEH A., BEN-CHETRIT E., GIANCANE G., et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016;75(4):644–651.
- LANCIERI M., BUSTAFFA M., PALMERI S., PRIGIONE I., PENCO F., PAPA R., et al. An update on familial Mediterranean fever. Int J Mol Sci. 2023;24(11):9584.
- HONG YS., MOON SJ., JOO YB., JEON CH., CHO ML., JU JH., et al. Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. J Korean Med Sci. 2011;26(9):1132–1139.
- MU R., HUANG HQ., LI YH., LI C., YE H., LI ZG. Elevated serum interleukin-33 is associated with autoantibody production in patients with rheumatoid arthritis. J Rheumatol. 2010;37(10):2006–2013.
- GEORGAKIS S., GKIRTZIMANAKI K., PAPADAKI G., GAKIOPOULOU H., DRAKOS E., ELORANTA ML., et al. NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLE. JCI Insight. 2021;6(21):e147671.
- YANG Z., LIANG Y., XI W., LI C., ZHONG R. Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population. Clin Exp Med. 2011;11(2):75–80.
- LI GX., WANG S., DUAN ZH., ZENG Z., PAN FM. Serum levels of IL-33 and its receptor ST2 are elevated in patients with ankylosing spondylitis. Scand J Rheumatol. 2013;42(3):226–231.
- CAYROL C., GIRARD JP. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9021–6.
- HE PY., WU MY., ZHENG LY., DUAN Y., FAN Q., ZHU XM., et al. Interleukin-33/serum stimulation-2 pathway: regulatory mechanisms and emerging implications in immune and inflammatory diseases. Cytokine Growth Factor Rev. 2024;76:112–126